Misonix to Participate at Upcoming Craig-Hallum and Canaccord Genuity Investor ConferencesGlobeNewsWire • 11/12/20
Misonix, Inc. (MSON) CEO Stavros Vizirgianakis on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/09/20
Misonix to Report Fiscal 2021 First Quarter Financial Results and Host Conference Call and Webcast on November 5GlobeNewsWire • 10/20/20
Misonix Reports Preliminary Fiscal 2021 First Quarter Revenue of Approximately $17.7 MillionGlobeNewsWire • 10/06/20
Misonix Enters Into Exclusive Supply and Distribution Agreement With Gunze Limited for TheraGenesis® Bilayer Wound MatrixGlobeNewsWire • 09/21/20
Misonix, Inc. (MSON) CEO Stavros Vizirgianakis on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 09/04/20
Misonix to Report Fiscal 2020 Fourth Quarter Financial Results and Host Conference Call and Webcast on September 3GlobeNewsWire • 08/06/20
Misonix Reports Preliminary Fiscal 2020 Fourth Quarter Revenue of Approximately $13.5 MillionGlobeNewsWire • 07/10/20
Misonix, Inc. (MSON) CEO Stavros Vizirgianakis on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/12/20
MISONIX REPORTS PRELIMINARY FISCAL 2020 THIRD QUARTER REVENUE OF APPROXIMATELY $17.9 MILLIONGlobeNewsWire • 04/02/20
Misonix, Inc. (MSON) CEO Stavros Vizirgianakis on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/06/20
Misonix Reports Preliminary Fiscal 2020 Second Quarter Revenue of Approximately $19.7 MillionGlobeNewsWire • 01/13/20
Misonix Announces Results of New Large Real-World Studies That Further Prove the Clinical Effectiveness of TheraSkinGlobeNewsWire • 12/05/19
Misonix, Inc. (MSON) CEO Stavros Vizirgianakis on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/11/19
Misonix, Inc. Completes Acquisition of Regenerative Medical Company Solsys MedicalGlobeNewsWire • 09/27/19
Misonix, Inc. (MSON) CEO Stavros Vizirgianakis on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/15/19